| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 123,637 | 98,318 | 110,335 | 132,382 | | Cost of Revenue | 85,590 | 65,966 | 74,557 | 86,225 | | | Gross Profit | 38,047 | 32,352 | 35,778 | 46,157 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,418 | 19,124 | 20,258 | 23,727 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 24,629 | 13,228 | 15,520 | 22,430 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 190 | 109 | 130 | (338) | | Earnings Before Interest And Taxes | 24,819 | 13,337 | 15,650 | 22,092 | | Interest Expense | 62 | 61 | 62 | 61 | | Income Before Tax | 24,757 | 13,276 | 15,588 | 22,031 | | Income Tax Expense | 8,690 | 4,917 | 5,464 | 8,254 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 16,067 | 8,359 | 10,124 | 13,777 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,067 | 8,359 | 10,124 | 13,777 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $16,067 | $8,359 | $10,124 | $13,777 |
|
0.31% Nasdaq 
0.05%
Income Statement
